6 HIV Persistence Workshop: advanced program available PDF Print E-mail
Written by Alain Lafeuillade   
Sunday, 28 April 2013 10:35

6 HIV Persistence Workshop: advanced program available!

AIDS-virus-HIVThe 6 International Workshop on HIV Persistence will be held in Miami, Fl (USA), 3-6 December 2013. This workshop is driven by Science and new data. Each session will start with 2 invited speakers, followed by selected abstracts. This workshop is recognized as the reference meeting on HIV reservoirs, latency, and eradication strategies. It was previously organized in Saint Martin and its new location in Miami will allow to increase the number of participants. The advanced program of this meeting is now available. 

 

 

The official website is at: http://www.informedhorizons.com/persistence2013

EmailBanner_PW2013_013113

Tuesday December 3

04:00-06:00 pm – Satellite Symposium

06:20-06:30 pm– Welcoming Message

06:30-07:00 pm– Opening Lecture: Robert Siliciano (John Hopkins University, Baltimore, USA) 

07:00-09:00 pm –Dinner


Wednesday December 4

08:00-10:00 am – Session 1: Basic Mechanisms of HIV Latency

Chairs: Carine Van Lint (Université Libre de Bruxelles, Gosselies, Belgium), Monsef Benkirane (CNRS, Montpellier, France)

  • Jonathan Karn (Case Western Reserve University, Cleveland, USA): ‘Signaling pathways and epigenetic mechanisms controlling HIV latency’ 

  • Melanie Ott (Glastone Institute of Immunology and Virology, San Franciso, USA): ‘Chromatin-modifying enzymes in HIV latency’

  • Selected Abstracts

10:00-10:30 am – Break, Posters

10:30-12:00 am – Session 2: Assays to Measure HIV Persistence

Chairs: Sarah Palmer (Westmead Millenium Institute for Medical Research and University of Sydney, Westmead, Australia), Douglas Richman (University of California San Diego/VA Medical Center, La Jolla, USA)

  • Janet Siliciano (John Hopkins University, Baltimore, USA): ‘Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies’  

  • Matthew Strain (University of California, San Diego, USA): ‘Quantitative Single-Cell Analysis of Persistent Infection’

  • Selected Abstracts

12:00-02:00 pm – Lunch

02:00-03:00 pm – Session 3: In vivo and in vitro Models of HIV Persistence

Chairs: Jose Alcami (Instituto de Salud Carlos III, Madrid, Spain), Vicente Planelles (University of Utah, Salt Lake City, USA)

  • Paul Luciw (UC Davis, Davis, USA): ‘Viral Reservoirs and Anti-Latency Interventions in Nonhuman Primate Models of SIV/SHIV Infection’  

  • University of North Carolina at Chapel Hill, Chapel Hill, USA): ‘In vivo Analysis of HIV Persistence and Eradication’

  • Selected Abstracts

03:00-04:00 pm – Session 4: Clinical Virology of HIV Persistence

Chairs: Christine Rouzioux (Hôpital Necker, Paris, France), John Coffin (Tufts University, Boston, USA)

  • Jacob Estes (SAIC-Frederick, Inc, Frederick, USA): ‘Understanding Lentiviral Persistence in vivo Using Nonhuman Primate Models’

  • Jason Brenchley (NIH, Bethesda, USA): ‘Does expression of Vpx by SIV facilitate infection of macrophages and resting CD4 T cells in vivo?’ 

  • Selected Abstracts

04:00-04:30 pm – Break, Posters

04:30-06:00 pm – Session 5: Anatomic and non-CD4 Cell Reservoirs

Chairs: Mario Stevenson (University of Miami - Miller School of Medicine, Miami, USA), Ashley Haase (University of Minnesota, Minneapolis, USA)

  • Timothy Schacker (University of Minnesota, Minneapolis, USA): ‘Title TBA’

  • Janice Clements (John Hopkins University School of Medicine, Baltimore, USA): ‘Title TBA’

  • Selected Abstracts

07:30-09:30 pm – Dinner


Thursday December 5

08:00-10:00 am – Session 6: Immunology of HIV Persistence

Chairs : Marie-Lise Gougeon (Institut Pasteur, Paris, France), Nicolas Chomont (VGTI-Florida, Port St. Lucie, USA)

  • Guido Silvestri (Emory University, Atlanta, USA): ‘Targeting Persistent Virus Reservoirs in SIV-infected NHPs’ 

  • Steven Deeks (University of California, San Francisco, San Francisco, USA): ‘Immune Dysfunction as a Potentially Reversible Barrier to Curing HIV Infection’

  • Selected Abstracts

10:00-10:30 am – Break, Posters

10:30-12:00 am – Session 7: Pharmacology of HIV Persistence

Chairs: Alain Lafeuillade (General Hospital, Toulon, France), Patrick Robinson (Boehringer Ingelheim, Ridgefield, USA)

  • Courtney Fletcher (University of Nebraska Medical Center, Omaha, USA): ‘Is There a Pharmacologic Basis for Persistent HIV Replication?’  

  • Angela Kashuba (University of North Carolina Eshelman School of Pharmacy, Chapel Hill, USA): ‘Current and Future Approaches to Quantifying the Relationship Between Pharmacology and HIV Persistence’  

  • Selected Abstracts

12:00-02:00 pm – Lunch

02:00-03:00 pm – Session 8: Late Breakers

Chairs: Alain Lafeuillade (General Hospital, Toulon, France), Mario Stevenson (University of Miami - Miller School of Medicine, Miami, USA)

03:00-04:00 pm – Session 9: Drug Discovery

Chairs: Mario Stevenson (University of Miami - Miller School of Medicine, Miami, USA), David Margolis (University of North Carolina at Chapel Hill, Chapel Hill, USA)

  • Daria Hazuda (Merck, West Point, USA): ‘Identification and Characterization of Small Molecule Inducers of HIV Latent Gene expression’

  • Steve Mason (Bristol – Myer Squibb, New York, USA): ‘Dual Approach to HIV-1 Cure: Activation of Latency and restoration of Exhausted Virus-specific T Cell Function’

  • Romas Geleziunas (Gilead Sciences, Inc, Foster City, USA):‘ Concepts of Combination Therapy for HIV Eradication’ 

  • Daniel Boden (Janssen, Beerse, Belgium): 'The Quest for HIV Reactivators' 

04:00-04:30 pm – Break, Posters

04:30-06:00 pm – Session 10: Acute HIV Infection and Functional Cure

Chairs: Deborah Persaud (John Hopkins University, Baltimore, USA), Andrew Spaltenstein (GlaxoSmithKline, Raleigh - Durham, USA)

  • Timothy Henrich (Brigham and Women's Hospital, Boston, USA): ‘Challenges and Strategies Towards Functional Cure: How low do you need to go? 

  • Katherine Luzuriaga (University of Massachusetts Medical School, Worcester, USA): ‘Virologic and immunologic characterization of HIV reservoirs in children following early therapy’ 

  • Selected Abstracts

07:30-09:30 pm – Dinner


Friday December 6

08:00-10:00 am – Session 11: New Therapeutic Approaches – Part I

Chairs : Andrea Savarino (Instituto Superiore Di Sanita, Rome, Italy), George Hanna (VGTI Bristol-Myers Squibb, Princeton, USA)

  • David Margolis (University of North Carolina at Chapel Hill, Chapel Hill, USA): ‘Translational Challenges in Targeting Latent HIV Infection’ 

  • Sharon Lewin (Monash University, Melbourne, Australia): ‘Activating Latent HIV with Vorinostat. The Knowns and Unknowns’

  • Thomas Rasmussen (Aarhus University Hospital, Skejby, Denmark): ‘Cyclic dosing of panobinostat to reverse HIV-latency: findings from a clinical trial’ 

  • Selected Abstracts

10:00-10:30 am – Break, Posters

10:30-12:00 am – Session 12: New Therapeutic Approaches – Part II

Chairs: Jose Gatell (Hospital Clinic, Barcelona, Spain), Mark Wainberg (McGill University AIDS Centre, Montreal, Canada)

  • Tae-Wook Chun (NIH, Bethesda, USA): ‘Therapeutic Strategies for Eliminating HIV Reservoirs’  

  • Hiroyu Hatano (University of California, San Francisco, USA): ‘Immune Activation and HIV Persistence: New Therapeutic Approaches.’ 

  • Jose Gatell (Hospital Clinic, Barcelona, Spain): ‘Update in HIV Therapeutic Vaccines and Immunotherapy’

  • Selected Abstracts

12:00-12:10 pm – Workshop Conclusion


Press Release



Key words: HIV Miami Workshop, HIV cure, HIV eradication, HIV persistence, HIV reservoirs, HIV workshop
Last Updated on Thursday, 09 May 2013 15:31
 

Gravatar
Tia Morton 16.08.2013 (14:47:07)  
Advanced program for persistence meeting requested Yes No  

I'm looking for the date by which abstracts must be submitted for the above-mentioned workshop

 
   
       
Gravatar
Alain Lafeuillade 23.08.2013 (14:11:42)  
Workshop Deadline Yes No  

Deadline for registration and abstract submission is September 6:
http://www.informedhorizons.com

Download the advanced program at:
http://www.informedhorizons.com/persistence2013/PDF/Program_Persistence.pdf

Kind regards,
The Steering Committee

 
   
       

Smileys

:confused: :cool: :cry: :laugh: :lol: :normal: :blush: :rolleyes: :sad: :shocked: :sick: :sleeping: :smile: :surprised: :tongue: :unsure: :whistle: :wink: 

  1000 Characters left

Antispam Refresh image Case sensitive